Posted by Dan Bedinger, PhD

High Throughput SPR (HT-SPR) can provide valuable insights to the kinetics and epitope coverage of large numbers of antibodies early in the drug discovery process. This information-rich data can be used broadly to understand clonal diversity in campaigns which incorporate NGS analysis and a wide range of antibody discovery workflows.

Watch this educational and informative webinar as Dr. Dan Bedinger discusses recently published examples of HT-SPR epitope binning and kinetics being applied to the rapid characterization of large panels of mAbs in viral neutralization discovery programs.